Personalis (PSNL) News Today $10.12 +0.99 (+10.84%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$9.88 -0.24 (-2.36%) As of 04:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PSNL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period AIGH Capital Management LLC Has $24.43 Million Holdings in Personalis, Inc. $PSNLOctober 20 at 4:13 AM | marketbeat.comPersonalis (NASDAQ:PSNL) Stock Price Down 10.7% - What's Next?October 18 at 12:45 PM | marketbeat.comPersonalis (NASDAQ:PSNL) Shares Up 9.1% - Still a Buy?October 17, 2025 | marketbeat.comPersonalis announces NeXT Personal data from AstraZeneca’s Phase 3 LAURA trialOctober 16, 2025 | msn.comPersonalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD TestingOctober 16, 2025 | finance.yahoo.comAberdeen Group plc Buys 54,713 Shares of Personalis, Inc. $PSNLOctober 16, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Reaches New 12-Month High - Here's What HappenedOctober 15, 2025 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Given Consensus Recommendation of "Moderate Buy" by BrokeragesOctober 12, 2025 | americanbankingnews.comPersonalis, Inc. (NASDAQ:PSNL) Given Consensus Recommendation of "Moderate Buy" by AnalystsOctober 12, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Given Sell (D-) Rating at Weiss RatingsOctober 10, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Reaches New 1-Year High - Here's What HappenedOctober 8, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Trading 8.9% Higher - Still a Buy?October 3, 2025 | marketbeat.comGoldman Sachs Group Inc. Has $998,000 Stock Position in Personalis, Inc. $PSNLSeptember 23, 2025 | marketbeat.comPersonalis management to meet with Piper SandlerSeptember 22, 2025 | msn.comPersonalis (NASDAQ:PSNL) Shares Up 7.5% - Here's WhySeptember 20, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Upgraded to Hold at Wall Street ZenSeptember 20, 2025 | marketbeat.comWith 42% ownership, Personalis, Inc. (NASDAQ:PSNL) has piqued the interest of institutional investorsSeptember 18, 2025 | finance.yahoo.comAcadian Asset Management LLC Sells 105,384 Shares of Personalis, Inc. $PSNLSeptember 18, 2025 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Given Consensus Rating of "Buy" by BrokeragesSeptember 17, 2025 | marketbeat.comPersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 15, 2025 | businesswire.comPersonalis (NASDAQ:PSNL) Trading Down 4.1% - Here's WhySeptember 14, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Stock Price Up 6.5% - What's Next?September 13, 2025 | marketbeat.comPersonalis' MRD Breakthrough Potential: Why I Hold Until Reimbursement Clarity EmergesSeptember 11, 2025 | seekingalpha.comPersonalis collaborates with Yale Cancer Center over CATE clinical trialSeptember 10, 2025 | msn.comCATE Clinical Trial Launched to Demonstrate the Clinical Utility of ctDNA-Guided Treatment in Breast Cancer Using the Ultrasensitive NeXT Personal TestSeptember 10, 2025 | businesswire.comPersonalis' (PSNL) "Buy" Rating Reaffirmed at HC WainwrightSeptember 10, 2025 | marketbeat.comPersonalis, Inc. $PSNL Stake Boosted by Trexquant Investment LPSeptember 10, 2025 | marketbeat.comPersonalis reports data from AstraZeneca phase 3 clinical trial in lung cancerSeptember 4, 2025 | msn.comPersonalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD TestingSeptember 3, 2025 | finance.yahoo.comPersonalis Earnings Call: Growth Amidst Financial ChallengesAugust 29, 2025 | theglobeandmail.comPersonalis to Participate in Upcoming Investor ConferencesAugust 27, 2025 | businesswire.comPersonalis, Inc. (NASDAQ:PSNL) Receives Consensus Rating of "Buy" from BrokeragesAugust 25, 2025 | marketbeat.comAberdeen Group plc Purchases 1,406,895 Shares of Personalis, Inc. $PSNLAugust 23, 2025 | marketbeat.comPersonalis gains as VA awards work order worth up to $13.5MAugust 22, 2025 | msn.comPersonalis Secures New VA Contract Task OrderAugust 22, 2025 | tipranks.comCathie Wood’s ARK Investment buys 133.3K shares of Personalis todayAugust 15, 2025 | msn.comPersonalis (NASDAQ:PSNL) Rating Lowered to Sell at Wall Street ZenAugust 10, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for Personalis Q3 Earnings?August 9, 2025 | marketbeat.comPersonalis, Inc. (NASDAQ:PSNL) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportAugust 8, 2025 | finance.yahoo.comPSNL | Personalis Inc. Annual Income Statement | MarketWatchAugust 7, 2025 | marketwatch.comPersonalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | msn.comPersonalis (NASDAQ:PSNL) Given New $8.50 Price Target at HC WainwrightAugust 7, 2025 | marketbeat.comPersonalis (NASDAQ:PSNL) Posts Earnings Results, Beats Expectations By $0.02 EPSAugust 6, 2025 | marketbeat.comPersonalis (PSNL) Q2 Revenue Falls 24%August 6, 2025 | fool.comPersonalis, Inc. (PSNL) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comPersonalis reports Q2 EPS (23c), consensus (24c)August 5, 2025 | msn.comPersonalis Reports Second Quarter 2025 Financial ResultsAugust 5, 2025 | finance.yahoo.comPersonalis Q2 2025 Earnings PreviewAugust 5, 2025 | msn.comPersonalis (NASDAQ:PSNL) Shares Down 7.4% - What's Next?July 30, 2025 | marketbeat.comPersonalis (PSNL) Projected to Post Earnings on TuesdayJuly 30, 2025 | marketbeat.com Get Personalis News Delivered to You Automatically Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PSNL Media Mentions By Week PSNL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PSNL News Sentiment▼0.520.50▲Average Medical News Sentiment PSNL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PSNL Articles This Week▼73▲PSNL Articles Average Week Get the Latest News and Ratings for PSNL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Personalis and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies HTFL News Today VCYT News Today CON News Today SGRY News Today GRAL News Today ADUS News Today ARDT News Today LFST News Today CELC News Today PACS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PSNL) was last updated on 10/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Personalis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Personalis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.